Kristina M Kraml

Title: Innovations by Kristina M Kraml

Introduction

Kristina M Kraml is an accomplished inventor based in Princeton, NJ. She has made significant contributions to the field of bacterial pathogenicity through her innovative research and patents. Her work focuses on understanding and manipulating bacterial communication systems to develop new treatment strategies.

Latest Patents

Kristina holds a patent titled "Identification of bacterial autoinducer and use in treating bacterial pathogenicity." This patent describes the purification and structural identification of a bacterial autoinducer known as CAI-1. The patent outlines methods for synthesizing the autoinducer and its analogues, as well as their application in treating bacterial pathogenicity and biofilm formation. Additionally, it details strategies for preventing and treating cholera, highlighting that synthetic (S)-3-hydroxytridecan-4-one functions similarly to natural CAI-1 in repressing the production of the virulence factor toxin co-regulated pilus (TCP). The patent emphasizes the potential for manipulating bacterial quorum sensing in clinical settings.

Career Highlights

Kristina M Kraml is affiliated with Princeton University, where she conducts her research. Her work has garnered attention for its innovative approach to addressing bacterial infections and pathogenicity. With a focus on practical applications, her research aims to improve treatment options for bacterial diseases.

Collaborations

Kristina has collaborated with notable researchers in her field, including Bonnie L Bassler and Martin F Semmelhack. These collaborations have further enriched her research and contributed to advancements in understanding bacterial communication and pathogenicity.

Conclusion

Kristina M Kraml's innovative work in identifying bacterial autoinducers and developing treatment strategies showcases her significant contributions to the field of microbiology. Her research not only enhances our understanding of bacterial behavior but also opens new avenues for combating bacterial infections.